Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Klinički bolnički centar Rijeka (Clinical Hospital Center Rijeka)

Verifiedinfo

Croatia Kresimirova 42, 51000 Rijeka, Croatia

  • 22 trials recruiting
  • Dementia Alzheimer's type · Type 2 diabetes mellitus · Psoriatic arthropathy
  • Adults and children

About Specializations

Klinički bolnički centar Rijeka (Clinical Hospital Center Rijeka) in Rijeka, Croatia specialises in clinical trials of conditions such as Dementia Alzheimer's type, Type 2 diabetes mellitus, Psoriatic arthropathy, Partial seizures, and other specialisations. This site conducts important research.

Main research areas of the site

Neurology and Epilepsy Research

The medical center is at the forefront of neurology research, with a particular focus on epilepsy. The institution is dedicated to advancing the understanding and treatment of refractory focal onset epilepsy, a challenging condition that requires innovative therapeutic approaches.

  • Refractory Focal Onset Epilepsy
  • Seizure Reduction Strategies
  • Adjunctive Therapy Development

Through its cutting-edge research, the center contributes significantly to the development of new therapies that aim to improve the quality of life for patients with difficult-to-treat epilepsy. The ongoing studies are pivotal in exploring the efficacy and safety of novel treatments, such as BHV-7000, in reducing seizure frequency.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Kresimirova 4251000 RijekaCroatia
Open in maps ↗
Recruiting now
22 trials
Conditions studied
41
Partner status
Verified

More sites in RijekaCroatia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

54 clinical trials

Type 2 diabetes mellitus+2

Recruiting
Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Dementia Alzheimer's type

Recruiting
InvestigationalNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Partial seizures

Recruiting
InvestigationalNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Bhv-7000
  • Sponsor:Biohaven Therapeutics Ltd.

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Recruiting
Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Arteriosclerosis

Recruiting
Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC

Atrial fibrillation

Recruiting
Investigational
Countries:CroatiaCroatia
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Pneumonia bacterial

Recruiting
Registered drugNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Ampicillin Sodium
  • Sponsor:Bioversys S.A.S.

Type 2 diabetes mellitus+1

Recruiting
Investigational
Countries:CroatiaCroatia
  • Participants:0–17 years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Secondary progressive multiple sclerosis

Recruiting
Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

A study comparing macrogol 3350 combination and sodium picosulfate for bowel cleansing before colonoscopy in children and teenagers with colonic disease

Recruiting
Registered drugNo placebo
Countries:CroatiaCroatia
  • Participants:0–17 years
  • Substances:Ascorbic Acid
  • Sponsor:Norgine Limited

Dementia Alzheimer's type

Recruiting
Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Dementia Alzheimer's type

Recruiting
Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.